HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-vivo investigations on dye-enhanced photothermal tumor therapy with a naphthalocyanine derivative.

Abstract
Chromophore-enhanced photothermal therapy involves the application of an exogenous chromophore in combination with irradiation, using an appropriate wavelength, exposure duration and sufficient irradiances. The chromophore palladium(II) octabutoxynaphthalocyanine (PdNc(OBu)8) accumulates at satisfactory concentrations and with good selectivity between both tumor and muscle and tumor and skin in tumor-bearing mice. In an attempt to thermally damage tumor tissue with concurrent sparing of adjacent normal tissue, the potential of PdNc(OBu)8 for photothermal therapy was investigated. Using a Balb/c mouse model with subcutaneously implanted EMT6 adenocarcinoma, 90-100 hours after intraperitoneal application of PdNc(OBu)8, the tumor and surrounding tissue were irradiated with a 826nm continuous-wave diode laser. The thermal effects on tumor and normal tissue were evaluated histologically. Our results indicate that after PdNc(OBu)8 administration and tumor irradiation using 5W/cm-for 100 seconds, pronounced selective heating of the tumor was achieved in mice, while in control animals merely an unspecific and marginal overall increase in temperature over the entire irradiation area was observed. Histological evaluation of treated areas indicated that the PdNc(OBu)8-targeted tumor tissue showed severe thermal damage while peripheral tissue like skin and muscle remained largely unaffected. This study shows the potential of creating localized thermal effects by using PdNc(OBu)8 and continuous-wave light for chromophore-enhanced photothermal therapy.
AuthorsHeyke Diddens, Frank Fischer, Roy H Pottier
JournalOftalmologia (Bucharest, Romania : 1990) (Oftalmologia) Vol. 56 Issue 1 Pg. 59-61 ( 2003) ISSN: 1220-0875 [Print] Romania
PMID12886685 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Organometallic Compounds
  • palladium 5,9,14,18,23,27,32,36-octabutoxynaphthalocyanine
Topics
  • Adenocarcinoma (therapy)
  • Animals
  • Disease Models, Animal
  • Female
  • Hindlimb
  • Lasers
  • Mice
  • Mice, Inbred BALB C
  • Organometallic Compounds (therapeutic use)
  • Photochemotherapy (methods)
  • Soft Tissue Neoplasms (therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: